NeoCura
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $117M
Investors
- 7
About NeoCura
Based in Shenzhen, China and established in 2017, NeoCura is pharmaceutical company that focuses on tumor field based on RNA technology. The company has additional offices in Beijing, and Guangzhou. The company has established multi-omics big data collection platform, and multi-bioomics database. The company use artificial intelligence (AI) algorithm plus test data for in-depth drug target mining and automated drug design to develop innovative drugs. The company has over 30 invention patents, including 10 patents are foreign inventions. The company won the 2021 China's Most Potential Enterprise, and 2021 China's TOP10 AI/Computing Pharmaceutical Innovation Enterprise. The company's R&D pipeline include tumor neoantigen vaccine, tumor microenvironment immunomodulation, and virus vaccine. The company self-developed artificial intelligence bio-information target mining platform, RNA drug platform, automated drug design, drug screening verification platform, multi-omics big data collection and analysis platform. The company plans to promote the R&D progress of tumor neoantigen vaccine, tumor microenvironment immunomodulation, and virus vaccine. Moreover, the company will optimize the AI platform, building plant, and accelerating to promote the innovate drug clinical and commercialization.
Who invested in NeoCura
7 investors across 2 rounds
See all investors in NeoCura
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeoCura
Who invested in NeoCura?
NeoCura has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeoCura raised?
NeoCura has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NeoCura last raise money?
NeoCura's most recent round on record is a Series A, in Dec 2021.
What does NeoCura do?
Based in Shenzhen, China and established in 2017, NeoCura is pharmaceutical company that focuses on tumor field based on RNA technology.
Where is NeoCura headquartered?
NeoCura is headquartered in Shenzhen, China.
Which VCs invest in companies like NeoCura?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NeoCura's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NeoCura? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.